EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.13 | ZL-031 | i.e. diethyl N-[4-[(2-[2,4-diamino-5-(2,3-dibromopropane)-5,6,7,8-tetrahydropyrido(3,2-d)pyrimidin-6-yl]methyl)amino]3-bromo-benzoyl]L-glutamate | Homo sapiens | |
2.1.1.13 | ZL-033 | i.e. N-[4-[(2-[2,4-diamino-5-(2,3-dibromopropane)-5,6,7,8-tetrahydropyrido(3,2-d)pyrimidin-6-yl]methyl)amino]3-bromo-benzoyl]L-glutamic acid | Homo sapiens | |
2.5.1.49 | diethyl N-[[3-bromo-4-([[2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl]amino)phenyl]carbonyl]glutamate | inhibition of methionine synthase, arrest of cell cycle in G1/S phase and apoptosis. Treatment results in increase in cyclin E and cyclin-dependent kinase 2, reduction of caspase-3, poly(ADP-ribose) polymerase, caspase-8, and caspase-9 protein levels | Homo sapiens | |
2.5.1.49 | N-[[3-bromo-4-([[2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl]amino)phenyl]carbonyl]glutamic acid | inhibition of methionine synthase, arrest of cell cycle in G1/S phase and apoptosis. Treatment results in increase in cyclin E and cyclin-dependent kinase 2, reduction of caspase-3, poly(ADP-ribose) polymerase, caspase-8, and caspase-9 protein levels | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.13 | Homo sapiens | - |
- |
- |
2.5.1.49 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.13 | HL-60 cell | - |
Homo sapiens | - |
2.5.1.49 | HL-60 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.13 | N5-methyltetrahydropteroylmonoglutamate + L-homocysteine | - |
Homo sapiens | tetrahydropteroylmonoglutamate + L-methionine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.13 | 5-methyltetrahydrofolate-homocysteine methyltransferase | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.1.1.13 | 0.0014 | - |
at 37°C | Homo sapiens | ZL-033 | |
2.1.1.13 | 0.01 | - |
at 37°C | Homo sapiens | ZL-031 | |
2.5.1.49 | 0.0014 | - |
pH 7.2, 37°C | Homo sapiens | N-[[3-bromo-4-([[2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl]amino)phenyl]carbonyl]glutamic acid | |
2.5.1.49 | 0.01 | - |
pH 7.2, 37°C | Homo sapiens | diethyl N-[[3-bromo-4-([[2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl]amino)phenyl]carbonyl]glutamate |